Switch to:
More From Other Websites
FDA Grants Vical Fast Track Designation for VL-2397 for the Treatment of Invasive Aspergillosis Mar 30 2016
FDA Grants Vical Fast Track Designation for VL-2397 for the Treatment of Invasive Aspergillosis Mar 30 2016
VICAL INC Financials Mar 18 2016
Vical, Inc. :VICL-US: Earnings Analysis: 2015 By the Numbers Mar 17 2016
VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 14 2016
Q4 2015 Vical Inc Earnings Release - Before Market Open Mar 14 2016
Vical reports 4Q loss Mar 14 2016
Vical reports 4Q loss Mar 14 2016
Vical Reports Fourth Quarter 2015 Financial Results Mar 14 2016
Investor Calendar Invites You to the Vical Fourth Quarter and Fiscal Year 2015 Earnings Webcast Live... Mar 11 2016
Vical to Present at the 28th Annual ROTH Conference Mar 09 2016
Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2015 Financial Results Mar 07 2016
Vical Initiates Phase 1 Trial of Novel Antifungal Compound VL-2397 Mar 07 2016
VICAL INC Files SEC form 8-K, Other Events Feb 04 2016
CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores Jan 18 2016
Vical's VL-2397 Gets Orphan Status for Invasive Aspergillosis Jan 07 2016
FDA Grants Vical Orphan Drug Designation for VL-2397 for the Treatment of Invasive Aspergillosis Jan 06 2016
Vical Appoints Dr. Thomas Shenk to Board of Directors Dec 21 2015
VICAL INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 21 2015
4 Stocks Under $10 to Trade for Big Breakouts Nov 29 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK